Literature DB >> 6618638

Baroreflex function in elderly hypertensives.

K McGarry, M Laher, D Fitzgerald, J Horgan, E O'Brien, K O'Malley.   

Abstract

Baroreflex function was assessed in elderly hypertensive patients and compared with that observed in young hypertensives and young normotensives. Mean arterial pressure was reduced by 20% using intravenous nitroprusside infusion in 10 elderly hypertensive patients (older than 65 years and diastolic pressures over 95 mm Hg), in 10 young hypertensives (under 60 years and diastolic pressures over 95 mm Hg), and in seven young normotensive subjects (under 60 years and diastolic pressures under 95 mm Hg). Elderly subjects demonstrated greater sensitivity (p less than 0.005) and greater variability of response (p less than 0.025) to nitroprusside than either young group. There was no significant difference between the slight heart rate increases observed in the supine position in the three groups. However, in the erect position, heart rate increases were significantly less in the elderly hypertensive group than in the young hypertensive group (p less than 0.01) or the young normotensive group (p less than 0.005). Furthermore, the slope of the regression line relating change in blood pressure with change in R-R interval was less for the elderly patients than for the young hypertensives (p less than 0.05) or the young normotensives (p less than 0.025). We conclude that the heart rate component of the baroreflex is impaired in elderly hypertensives, and anticipate that the clinical response to antihypertensive drugs will be altered.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6618638     DOI: 10.1161/01.hyp.5.5.763

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.

Authors:  A Hämmerlein; H Derendorf; D T Lowenthal
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

2.  Factors affecting variability in home blood pressure in patients with type 2 diabetes: post hoc analysis of a cross-sectional multicenter study.

Authors:  E Ushigome; M Fukui; M Hamaguchi; T Tanaka; H Atsuta; S-i Mogami; Y Oda; M Yamazaki; G Hasegawa; N Nakamura
Journal:  J Hum Hypertens       Date:  2014-02-06       Impact factor: 3.012

Review 3.  Nitrates in the elderly. Pharmacological considerations.

Authors:  J G Kelly; K O'Malley
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

Review 4.  Hypertension in the elderly: epidemiology and pathophysiology.

Authors:  J J McNeil; C A Silagy
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

5.  Carotid barochemoreceptor pathological findings regarding carotid plaque status and aging.

Authors:  José Milei; Anna M Lavezzi; Barbara Bruni; Daniel R Grana; Francisco Azzato; Luigi Matturri
Journal:  Can J Cardiol       Date:  2009-01       Impact factor: 5.223

6.  Impact of demographic trends on cardiovascular therapy during the next decade.

Authors:  W H Birkenhäger; P W de Leeuw
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 7.  Mechanisms and management of stroke in the elderly.

Authors:  A Shuaib; V C Hachinski
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

Review 8.  Calcium antagonists in the elderly.

Authors:  J G Kelly; K O'Malley
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.